Related Experiment Video
Updated: Jun 13, 2025

The Measurement and Treatment of Suppression in Amblyopia
Published on: December 14, 2012
Successful persistent strabismic amblyopia treatment using active therapy as an adjuvant to occlusion
Irene Sanchez1, Santiago Martin-Gonzalez2, Juan Antonio Portela-Camino3
1Departamento de Física Teórica, Atómica y Óptica, Universidad de Valladolid, Valladolid, Spain; Optometry Research Group, IOBA Eye Institute, University of Valladolid, Valladolid, Spain.
This study introduces a new amblyopia treatment combining home-based perceptual learning and clinic therapy. The novel protocol significantly improved visual acuity and stereoacuity in patients with persistent amblyopia.
Area of Science:
- Ophthalmology
- Neuroscience
- Vision Science
Background:
- Amblyopia, or 'lazy eye', affects visual development and can persist into adulthood.
- Conventional treatments like patching have limitations, especially for persistent or 'patch-resistant' amblyopia.
- Novel therapeutic approaches are needed to improve long-term outcomes for amblyopia patients.
Purpose of the Study:
- To evaluate a novel treatment protocol for persistent strabismic and combined-mechanism amblyopia.
- The protocol integrates home-based perceptual learning (PL) with traditional in-clinic visual therapy.
- This approach aims to enhance outcomes beyond standard patching for patch-resistant amblyopia.
Main Methods:
- A cohort of 53 patients with persistent amblyopia (strabismic or combined-mechanism) were treated between 2018-2022.
- The protocol involved in-clinic orthoptics and visual therapy.
- Home-based therapy utilized gamified perceptual learning software (Gabor patch, dichoptic stimulation, random dot stereograms).
Main Results:
- 87% of patients achieved a best-corrected visual acuity (BCVA) of logMAR 0.1 or better.
- Mean BCVA improved significantly from logMAR 0.30±0.23 to logMAR 0.07±0.12 (p < 0.01).
- Stereoacuity improved significantly, with 81% achieving measurable stereoacuity post-treatment (p < 0.01).
- Central fixation was achieved in 65% of patients with initial eccentric fixation.
Conclusions:
- The novel protocol effectively improved BCVA and stereoacuity in patients with persistent amblyopia.
- Reduced angle of deviation was also observed as an outcome.
- Treatment gains remained stable six months post-therapy, indicating long-term efficacy.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Direct-Acting Cholinergic Agonists: Therapeutic Uses

